Advertisement

Activation of the Thrombopoietin Receptor by Mutant Calreticulin in CALR-Mutant Myeloproliferative Neoplasms

Results from a recent study indicate that mutant CALR may promote myeloproliferative neoplasm development by activating c-MPL and its downstream pathway.

 Blood

click me